TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

HLTHCARE

Pharmaceuticals
Generics

HLTHCARE is a generic drug manufacturer with 1 FDA-approved products.

2012
Since
1
Drugs
-
Trials
13
Approved (2yr)

Key Drugs

No active drugs

Recent Activity

DOXORUBICIN HYDROCHLORIDE 2026-02-03
DOXORUBICIN HYDROCHLORIDE 2025-06-25
Labeling
DOXORUBICIN HYDROCHLORIDE 2025-06-25
Labeling
DOXORUBICIN HYDROCHLORIDE 2025-06-25
Labeling
DOXORUBICIN HYDROCHLORIDE 2025-06-03
Labeling
DOXORUBICIN HYDROCHLORIDE 2025-06-03
Labeling
DOXORUBICIN HYDROCHLORIDE 2025-06-03
Labeling
DOXORUBICIN HYDROCHLORIDE 2024-08-28
Labeling
DOXORUBICIN HYDROCHLORIDE 2024-08-28
Labeling
DOXORUBICIN HYDROCHLORIDE 2024-08-28
Labeling
SEC Filings Pro
Loading...

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

No indication data

Pipeline Strength Pro

Loading...